Drug Formulary Review Archives – November 1, 2003
November 1, 2003
View Issues
-
Study confirms importance of hands-on patient care
A study published in 1999 showed that having a pharmacist on a physician rounding team in an intensive care unit (ICU) reduced the incidence of adverse drug events (ADEs) by two-thirds. -
New dosing brings daptomycin to approval
Pharmacists now have another antibiotic to use in the treatment of complicated skin and skin structure infections. -
FDA counterfeit task force issues interim report
The Food and Drug Administrations (FDAs) Counterfeit Drug Task Force has issued its interim report outlining potential options for an approach to combat counterfeit drugs. -
News Briefs
Evaluations may be based on faulty assumptions; FDA, Customs finds potentially dangerous drug shipments; Color in enteral feeding tube linked to toxicity, death; Antiviral agent causes adverse effects in SARS patients -
New FDA Approvals
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA): -
New breakthrough in HIV treatment
Fuzeon (enfuvirtide), also known as T-20, was granted accelerated approval by the U.S. Food and Drug Administration (FDA) in March 2003. It is the first drug in a unique class of antiretrovirals, known as fusion inhibitors. Enfuvirtide is the newest development in drugs used to treat the human immunodeficiency virus (HIV-1). -
Nasal mupirocin to prevent S. aureus infections
Staphylococcus aureus causes 25% of nosocomial infections and is the most frequent cause of surgical site infections. The organism can be found colonized on the skin and nasopharynx and is transmitted via person-to-person contact or through inhalation of the organism. -
Review of cardiovascular/ coagulation adverse drug reaction trends
Adverse drug reactions (ADRs) are common occurrences in hospitals. Historically, the incidence of ADRs in hospitalized patients ranges from 6% to 20%, and 3% to 7% of hospital admissions have been attributed to ADRs. -
Drug-induced Stevens-Johnson syndrome
Stevens-Johnson syndrome (SJS) is an acute life-threatening condition, with an incidence of one to six cases per 1 million person-years. SJS occurs most often in otherwise healthy children and young adults; males are at higher risk than females. -
In the Pipeline
In the Pipeline -
2003 Salary Survey Results
2003 Salary Survey Results